Injective News and DeFi Protocol Insights
8.13
0.04
0.50 %
Real-time price
18:28
USD
Daily range
8.06
8.29
8.29
Weekly range
6.82
8.58
8.58
Crypto market steadies as bitcoin holds above $80,000, Injective jumps on ETF listing approval
Crypto prices are stabilizing after a broader risk rally lifted bitcoin from roughly $78,000 on Wednesday to above $80,000 heading into Thursday trading. The move is unfolding as U.S. spot bitcoin ...
Injective rises around 10.5% as Nasdaq approves Canary Capital's Staked Injective ETF
Injective (INJ) surged 10.55% after Nasdaq approved Canary Capital's Staked Injective ETF, marking the asset's first regulated US listing and channel for institutional inflows. The move is ...
Injective secures Nasdaq ETF approval: INJ gains momentum
Injective (INJ) is trading at $8.01, up 8.02% on the day. The asset currently sits above its key moving averages, reflecting continued upward momentum within the ...
Injective rises nearly 11% as Nasdaq approves Canary Capital's Staked INJ ETF listing
Injective (INJ) surged 10.73% after Nasdaq approved the listing application for Canary Capital's Staked INJ ETF, driving fresh institutional interest in the token. The move is supported by strong ...
Injective extends upward price move as buyers support rally
Injective (INJ) is trading at $7.48, gaining 7.33% on the day and nearing the high of its daily range with moderate volatility. The asset holds above its key moving ...
Injective tests key support zone amid heightened volatility and institutional developments: weekly analysis
Injective (INJ) slid to around $7.00 this week, losing nearly 10% as several technical indicators show mixed signals. A sharp drop brought oversold conditions, putting ...
Injective technical analysis: Upward price move approaches $7.72 resistance
Injective (INJ) is trading at $7.4 after advancing 7.03% on the day. The asset remains above its key moving averages, with firm price action and notable upside ...
Injective drops almost 11% after renewed ecosystem support triggers selling pressure
Injective (INJ) fell 10.76%, with selling pressure intensifying after its Trench Treasury acquired 5% of the $RUNNER token supply as part of ongoing ecosystem initiatives. The down move is limited ...
Injective holds $6.82 support amid weak momentum and continued downward price move
Injective (INJ) is trading at $7.18, down 7.92% over the last 24 hours. The price is currently below key short- and medium-term moving averages, while holding above ...
Injective drops about 9.5% after Community BuyBack and permanent INJ token burn
Injective (INJ) slumped 9.53% after selling pressure intensified, even as the network completed a Community BuyBack and permanently burned a significant amount of tokens. The decline is reinforced ...
Stretched seven-day slide amid heightened volatility: Injective weekly outlook—Can INJ stabilize above support?
Regulatory momentum is in focus this week as Injective trades near $7.8, having fallen almost 9% over the past seven days. Mounting speculation surrounds stablecoin frameworks in South Korea, ...
Injective price outlook: Upward momentum remains despite overbought signals
Injective (INJ) is trading at $8.08, up 7% on the day. The price is holding well above its short- and medium-term moving averages, reflecting strong near-term ...
Accelerated exchange deposits weigh on Injective price as sellers dominate
Injective (INJ) is trading at $8.13, falling 7.08% on the day. The asset sits below its key short- and medium-term moving averages, indicating prevailing downside ...
Injective posts upward price move as buyer support strengthens in volatile trade
Injective (INJ) is trading at $9.02, gaining 6.91% on the session. The asset is positioned above its key moving ...
Injective and BDACS partner to expand won stablecoin settlement in South Korea's tokenized asset market
South Korea's push to build a regulatory framework for won-denominated stablecoins is driving new infrastructure plans for tokenized asset markets. Injective and BDACS say their partnership is ...
Injective weekly outlook: Can overbought signals on CCI threaten the nearly 7% advance?
Regulatory engagement is shaping the outlook for Injective (INJ) this week, with the asset trading near $8.50 after gaining roughly 6% over the past seven days. ...
Injective surpasses $1.1B RWA volume: Can INJ sustain recent upside momentum?
Injective (INJ) is trading at $8.66 after a 7.18% gain on the day, maintaining a strong position above its key moving averages amid notable daily upside ...
INJ slides more than 10% as heavy selling hits despite ETF proposals and solid protocol metrics
Injective (INJ) fell 10.17% today as heavy intraday selling pressure outweighed recent positive protocol and governance developments. The decline is reinforced by the asset testing the lower end ...
INJ climbs more than 29% after institutional partnerships and SEC-registered status
Injective (INJ) spiked 29.07% after securing key regulatory milestones, with institutional partnerships and an SEC-registered transfer agent status increasing investor demand. The surge is ...
Injective upward price move as institutional interest and strong volumes support rally
Injective (INJ) is trading at $9.25 after climbing 27.57% over the past day, with the move keeping the asset above its key moving ...
Injective falls amid sustained selling pressure
Injective (INJ) is trading at $7.28, down 8.93% on the day after a volatile session that saw the asset open with a notable $0.32 gap. The price currently sits below its ...
